CHRS: Coherus Oncology, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-07-27 | New 13G stake | BlackRock, Inc. | 5.80% | SEC |
Institutional ownership (Q2 2026)
146 institutions reported holding $94.75M of Coherus Oncology, Inc. on Form 13F (158 the quarter before). 10 opened a new position and 20 sold out. Shares held by institutions: -2%.
| Largest holders | Shares | Value |
|---|---|---|
| Timothy G. Youngquist 2020 Irrevocable Trust | 13,050,623 | $18.27M |
| BlackRock, Inc. | 12,003,316 | $16.80M |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,949,490 | $8.33M |
| GEODE CAPITAL MANAGEMENT, LLC | 3,685,567 | $5.16M |
| SAMSARA BIOCAPITAL, LLC | 3,428,571 | $4.80M |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $4.18M |
| STATE STREET CORP | 2,382,305 | $3.34M |
| TWO SIGMA INVESTMENTS, LP | 2,259,412 | $3.16M |
| CM Management, LLC | 2,100,000 | $2.94M |
| Alyeska Investment Group, L.P. | 1,733,234 | $2.43M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.